Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...

Chemotherapy drugs in over 100 countries fail quality tests, putting cancer patients at risk of ineffective treatments.